Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial

cafead

Administrator
Staff member
  • cafead   Jan 24, 2025 at 11:52: AM
via Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and Lenvima didn’t exactly go their way.

article source